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Introduction: Granulomatous lesions are commonly encountered abnormalities in pulmonary pathology, and often
pose a diagnostic challenge. We report an unusual case of granulomatous lung disease with uncommon
characteristics, which developed following Epstein-Barr-virus-induced mononucleosis and new-onset systemic lupus
erythematosus. We aim to highlight a diagnostic approach for the condition and to raise awareness of the
possibility of it being related to the immunological reaction caused by Epstein-Barr virus infection.
Case presentation: A 36-year-old Japanese man, who had been diagnosed with Epstein-Barr-virus-induced
infectious mononucleosis, new-onset systemic lupus erythematosus, and secondary Sjögren’s syndrome three
weeks previously, presented to our facility with fever and diffuse pulmonary infiltrates. A computed tomography
scan of the chest revealed multiple small nodules in both lungs. Fiberoptic bronchoscopy with bronchoalveolar
lavage revealed lymphocytosis with predominance of T lymphocytes. A histological examination of a lung biopsy
taken during video-assisted thoracic surgery showed randomly distributed tiny granulomatous lesions with
infiltration of eosinophils. The differential diagnoses included hypersensitivity pneumonitis, sarcoidosis, and
pulmonary involvement of Crohn’s disease, systemic lupus erythematosus, and Sjögren’s syndrome, but the clinical
and pathological findings were not consistent with any of these. Our patient’s condition did not improve; therefore,
prednisolone therapy was started because of the possibility of specific immunological reactions associated with
Epstein-Barr virus infection. After steroid treatment, our patient showed radiological and clinical improvement.
Conclusions: To the best of our knowledge, this is the first case of a patient developing randomly distributed
multiple granulomatous lung lesions with eosinophilic infiltrates after Epstein-Barr virus infection and systemic lupus
erythematosus. On the basis of our data, we hypothesize that Epstein-Barr virus infection altered the immune
response of our predisposed patient and contributed to the pathogenesis of the lung lesions. Our patient’s clinical
response to steroid treatment was excellent.
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Granulomatous lesions are commonly encountered ab-
normalities in pulmonary pathology. Most granulomas
in the lung are caused by mycobacterial or fungal infec-
tions; however, if no organisms are detected, then it is
necessary to consider non-infectious causes of granu-
lomatous disease such as sarcoidosis, hypersensitivity
pneumonitis, hot tub lung, Wegener’s granulomatosis,
and Churg-Strauss syndrome [1].
We report an unusual case of granulomatous lung dis-
ease that differed from the above-mentioned entities,
which developed following Epstein-Barr virus (EBV)-
induced mononucleosis and new-onset systemic lupus
erythematosus (SLE) in our patient.
EBV has been linked to SLE for 40 years, and a grow-
ing body of experimental evidence supports a possible
role for EBV in the etiology of SLE [2,3], but the clear
mechanism of this linkage has not been elucidated. Al-
though there have been several case reports linking EBV
and SLE [4,5], to the best of our knowledge this is the
first case of a patient who developed multiple eosino-
philic granulomatous lesions in the lung after the diag-
nosis of new-onset SLE following EBV-induced
mononucleosis.
This case report highlights a diagnostic approach for
granulomatous lung disease and aims to raise awareness
of the possibility of the connection between granuloma-
tous lung disease and immunological reaction caused by
EBV.
Case presentation
A 36-year-old Japanese man, with a history of presumed
Crohn’s disease at age 16 years, on the basis of peri-anal
fistula with compatible histopathological features and
spontaneous healing without medical intervention, pre-
sented to our facility with a 10-day history of fever (39°C
to 40°C), malaise and generalized lymphadenopathy. He
also had a history of photosensitivity and erythema on
the cheeks and nose over the past five years, which had
worsened over the previous two days. Our patient had
no history of smoking or asbestos exposure. On examin-
ation, he was febrile and had tachypnea. He had a bilat-
eral malar rash, tender cervical lymphadenopathy,
swelling of parotid and submandibular glands, and arth-
ritis affecting the bilateral metacarpophalangeal joints of
the hands. He also had a dry mouth and dry eyes, which
were confirmed by a positive Schirmer’s test (<5mm per
five minutes, bilaterally). Auscultation of the heart and
lungs was normal. His abdomen was remarkable for
moderate hepatomegaly and splenomegaly.
On admission, his laboratory test results showed:
leukocytosis (white blood cells 13,090 cells/μL; lympho-
cytes 57.4%, atypical lymphocytes 10.0%); elevated liver
enzymes (alanine aminotransferase 202U/L (normalrange 10 to 40U/L), aspartate aminotransferase 172U/L
(normal range 13 to 30U/L), alkaline phosphatase
1332IU/L (normal range 100 to 320IU/L), γ glutamyl-
transpeptidase 223IU/L (normal range 5 to 60IU/L), lac-
tate dehydrogenase 561IU/L (normal range 110 to
210IU/L)); and normal renal function and urine analysis
with serum angiotensin-converting enzyme 16.4U/L
(normal range 7 to 25U/L). Serum serological tests were
positive for anti-nuclear antibody 1:80 (normal value
<1:40), double-stranded DNA (dsDNA) antibodies
22IU/mL (normal value <10IU/mL), and anti-Sjögren
syndrome antigen A (SS-A)/Ro antibody >500 (normal
value <10).
Virological test results for human immunodeficiency
virus antibody, cytomegalovirus antigen and antibody,
hepatitis B surface antigen and antibody, hepatitis C
virus antibody were negative, but our patient was posi-
tive for IgG and IgM to EBV viral capsid antigen and
IgG to EBV early antigen. Our patient was negative for
IgG to Epstein-Barr nuclear antigen (EBNA). A chest X-
ray was clear and computed tomography (CT) revealed a
small amount of pleural effusion in addition to lymph-
adenopathy in bilateral cervical, mediastinal and periton-
eal areas, and hepatosplenomegaly. A neck lymph node
biopsy showed positive expression of EBV-encoded RNA
by in situ hybridization, and the presence of serum EBV
DNA was confirmed by polymerase chain reaction
(PCR). Based on our patient’s clinical course, a diagnosis
of EBV-associated infectious mononucleosis, SLE and
secondary Sjögren’s syndrome was made, with a SLE
Disease Activity Index (SLEDAI) score of 11.
His serum lactate dehydrogenase and alkaline phos-
phatase levels gradually improved after three weeks of
hospitalization, with no treatment. Improvement was
also shown on physical examination, and our patient
was discharged on day 21.
Two weeks after initial hospitalization, he presented with
high fever and mild dyspnea on exertion. Physical examin-
ation was unremarkable except for high fever (40°C) with
SaO2 of 98% in room air. PCR results for serum EBV DNA
were negative and the titers for anti-nuclear antibody
(ANA) and anti-dsDNA antibodies declined to low levels,
with no clinical signs of SLE exacerbation (SLEDAI score of
3). A chest X-ray revealed interstitial infiltration in both
lungs (Figure 1), and a chest CT scan showed diffuse, ran-
domly distributed, ill-defined centrilobular micronodules
with patchy ground glass opacity in both lung fields
(Figure 2). Pulmonary function tests revealed impaired gas
diffusion with a forced vital capacity (FVC) of 129.2% of
predicted values, forced expiratory volume in one second
(FEV1) of 100.8% of predicted values, FEV1/FVC of 72.8%,
and diffusion capacity of the lung for CO (DLCO) of 66.2%
of the predicted value. Fiberoptic bronchoscopy with
bronchoalveolar lavage revealed markedly increased cell
a b
Figure 1 Chest radiographs taken at our patient’s first (a) and second (b) admission. The chest radiograph from the second admission (b)
showed a bilateral interstitial pattern.
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neutrophils, 1% eosinophils and 14% macrophages. Flow
cytometry revealed a predominance of T lymphocytes
(99%), with 35.6% CD4+ and 62.8% CD8+ cells; the ratio of
CD4+/CD8+ was 0.57.Figure 2 High-resolution chest computed tomography (CT)
scan taken at our patient’s second admission. The CT scan
shows diffuse, randomly distributed, ill-defined, centrilobular
micronodules with patchy ground glass opacity in both lung fields.On the basis of our patient’s medical symptoms, the
differential diagnoses included hypersensitivity pneu-
monitis (HP), EBV-related lymphomatoid granulomato-
sis, lymphocytic interstitial pneumonia secondary to
Sjögren’s syndrome and SLE, and sarcoidosis. To con-
firm the diagnosis, a lung biopsy was obtained by video-
assisted thoracic surgery, and sections from the right
middle lobe revealed nodular lesions measuring up to
1 mm in size, containing well-formed, non-necrotizing,
epithelioid cell granulomas, comprising lymphocytes,
plasma cells, and eosinophils on hematoxylin and eosin
staining, whereas peri-bronchiolar cellular infiltration
and alveolitis were unremarkable (Figure 3). These
lesions were randomly located within the central air-
spaces of the lung, and did not show bronchiolocentric
distribution, which is commonly seen in patients with
HP. The results of tissue stains and cultures for bacteria,
mycobacteria and fungi were all negative, and EBV-
encoded RNA expression in the lung was not detected
by in situ hybridization. Immunohistochemical staining
results for S-100 protein were also negative.
HP was considered as a possible etiology of our
patient’s symptoms. However, our patient was not
known to have been exposed to any inhaled agents, nor
did he show any clinical improvement during
hospitalization. In addition, the histopathological fea-
tures of the lung biopsy were not typical of those of HP.
The other possibilities, such as sarcoidosis, pulmonary
involvement of Crohn’s disease, SLE, and Sjögren’s syn-
drome were also considered to be unlikely based on clin-
ical and pathological findings.
Our patient’s condition did not improve: he had con-
tinued daily high-grade fever, and there was no
ba
Figure 3 Lung biopsy revealing non-necrotizing granulomas with infiltration of eosinophils (a, b). Video-assisted thoracic surgical lung
biopsy stained with hematoxylin and eosin ((a), ×30; (b) × 150). There were nodular lesions measuring up to 1 mm in size, containing well-formed,
non-necrotizing, epithelioid cell granulomas, various types of inflammatory cell infiltration including eosinophils, and exudates of fibrin. These
were randomly distributed in the central air spaces of the lung.
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olone therapy was started at a dose of 0.5mg/kg/day, as
a result of the possibility of specific immunological reac-
tions associated with EBV infection. Our patient showed
remarkable clinical and radiological improvement, and
he was discharged on a tapering dose of prednisolone.
After one year of follow-up, our patient remained
asymptomatic and had no relapse after discontinuation
of prednisolone. Physical examination and chest X-ray
/CT results were normal. Serological studies showed an
absence of ANA and anti-dsDNA antibodies, and the
presence of anti-SS-A/Ro antibodies, EBNA IgG, and
anti-smooth muscle antigen antibodies.
Discussion
Recent research has revealed that EBV is a strong candi-
date etiological agent for SLE, based on pleiotropic inter-
actions with host immune responses, such as molecular
mimicry, adjuvant or bystander effects, and interferon
(IFN)α induction [2,6,7]. Our patient had photosensitiv-
ity and butterfly rash five years before the diagnosis of
SLE and his symptoms of lupus, such as pleural fluid
and arthritis, resolved spontaneously after the acute
phase of EBV infection. Considering the clinical course,
he might have had unrecognized subclinical SLE severalTable 1 Classification of non-infectious granulomatous lung d
necrosis






Nodular Necrotizingyears before the diagnosis, and EBV infection might have
influenced his immune response and played a crucial
role in the pathogenesis of SLE and the onset of clinical
manifestations.
In addition, our patient developed multiple tiny, well-
formed granulomatous lesions in the lung three weeks
after the diagnosis of primary EBV-induced infectious
mononucleosis, new-onset SLE, and Sjögren’s syndrome.
Infectious causes, such as tuberculosis, atypical myco-
bacterial infection, and fungi, were excluded based on
histochemical staining, cultures, and PCR. Drug-induced
pneumonitis was also excluded.
Therefore, non-infectious granulomatous lung diseases
were considered in the differential diagnosis. Histological
characteristics of major non-infectious granulomatous
diseases are summarized in Table 1, according to the
distribution and the presence of necrosis.
HP, which is a diffuse granulomatous interstitial lung
disease caused by inhalation of various agents, was con-
sidered based on our patient’s radiological and histo-
pathological findings. Although the diagnosis of HP is
often difficult to make [8], in our patient HP was un-
likely given the lack of a history of exposure to occupa-
tional and domestic agents, and the fact that the lung
biopsy lacked the characteristic features of HP, such asiseases according to the distribution and the presence of
Disease
Hypersensitivity pneumonitis, lymphocytic interstitial pneumonia, talcosis
Histiocytosis X
Sarcoidosis, chronic beryllium disease
Wegener’s granulomatosis, lymphomatoid granulomatosis
Churg-Strauss syndrome
Rheumatoid nodule
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the interstitium, even in areas where no granulomas are
present, and poorly formed interstitial granulomas [9].
Furthermore, our patient failed to respond to removal
from antigen exposure by hospitalization. Serological
study results were negative for precipitating antibodies
to fungal antigens, such as Aspergillus sp. and Trichos-
poron cutaneum.
Another possibility that we considered was sarcoidosis.
Histologically, sarcoidosis is characterized by well-
formed interstitial, non-caseating granulomas, which
show lymphangitic distribution [10]. In our patient, the
distribution was different from that of sarcoidosis, and
his serum angiotensin-converting enzyme level was
normal.
Crohn’s disease, which shares pathological and im-
munological features with sarcoidosis [11] and can de-
velop granulomatous lung disease as extra-intestinal
involvement [12], was also considered to be unlikely, be-
cause the evidence of gastrointestinal involvement of
Crohn’s disease was not confirmed by upper endoscopy
and colonoscopy.
Furthermore, we raised the possibility that the pul-
monary manifestation was associated with SLE and Sjög-
ren’s syndrome. Pulmonary involvement is frequently
seen in SLE [13], and there is a case report of acute
granulomatous lupus pneumonitis [14]. Sjögren’s syn-
drome, which shares similar clinical and radiographic
features with sarcoidosis [15], is also known to demon-
strate various types of pulmonary manifestations, includ-
ing granulomatous infiltrations [16]. Even though SLE
and Sjögren’s syndrome seemed to be in a dormant state
when our patient developed pulmonary manifestations,
and granulomatous lesions are not typical findings of
these conditions, we cannot exclude the possibility that
these lesions were attributable to SLE and Sjögren’s
syndrome.
Lastly, EBV was considered as a possible etiological
agent. Lymphomatoid granulomatosis, which is a rare
EBV-associated lymphoproliferative disorder, was
excluded histopathologically, and there have been no
reports to suggest involvement of EBV in granulomatous
reactions in the lung, which can be seen in the spleen,
bone marrow and liver [17,18]. However, considering the
fact that EBV is known to cause pleiotropic interactions
with host inflammatory responses, and in the present
case, played a crucial role in the development of SLE
clinically, we hypothesize that EBV infection might have
altered the immune response and contributed to the
pathogenesis of the lung lesions through aberrant T cell
responses, dysregulated IFN and other cytokines
responses, and dysfunctional CD8 responses [2,3,6,7].
Rapid improvement in the symptoms by administration
of prednisolone also supports an immunological process.Conclusions
We describe the case of a patient who developed ran-
domly distributed multiple granulomatous lung lesions
with eosinophilic infiltrates, following EBV infection and
new-onset SLE. Although we cannot fully explain the
linkage between these conditions, we think that the im-
munological reaction induced by EBV contributed to the
pathogenesis of the lung lesions, as well as the onset of
SLE. His clinical and radiological response to prednisol-
one was excellent.Consent
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